Corbus Pharmaceuticals (NASDAQ:CRBP) Lowered to Sell at StockNews.com

StockNews.com lowered shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning. A number of other brokerages have also recently issued reports on CRBP. Royal Bank of Canada assumed coverage on Corbus Pharmaceuticals in a research report on Monday, May 13th. […]

Related Keywords

Canada , ,Securities Exchange Commission ,Corbus Pharmaceuticals Company Profile ,News Ratings For Corbus Pharmaceuticals Daily ,Corbus Pharmaceuticals ,Altitude Crest Partners Inc ,Corbus Pharmaceuticals Stock Performance ,Royal Bank ,Pricet Rowe Associates Inc ,Institutional Investors Weigh In On Corbus Pharmaceuticals ,Janus Henderson Group ,Jefferies Financial Group ,Mirae Asset Global Investments Co ,Corbus Pharmaceuticals Holdings Inc ,Free Report ,Get Free Report ,Cormorant Asset Management ,Exchange Commission ,Asset Global Investments ,Crest Partners ,Pharmaceuticals Holdings ,Corbus Pharmaceuticals Daily ,